-Kenji Ikeda Researcher Activity Profile

Research Author Detailed Information 

Kenji Ikeda Publication Rate By Year

Kenji Ikeda has published 1 paper(s) in 2006, 18 paper(s) in 2007, 10 paper(s) in 2008, for a total of 29 research publications in total.

Kenji K Ikeda Author Information

LAST NAME: ikeda

FIRST NAME: kenji

INITIALS: K

AFFILIATION:

Papers

Kenji Ikeda's Publication Record

1. Cost-effectiveness of radiofrequency ablation and surgical therapy for small hepatocellular carcinoma of 3cm or less in diameter. Year Published: 2006
Department of Gastroenterology, Toranomon Hospital, Okinaka Memorial Institute for Medical Research, Toranomon 2-2-2, Minato-ku 105-8470, Tokyo, Japan.
2. Diabetes mellitus increases the risk of hepatocarcinogenesis in patients with alcoholic cirrhosis: A preliminary report. Year Published: 2007
Department of Hepatology, Toranomon Hospital and the Okinaka Memorial Institute for Medical Research, Tokyo, Japan.
3. Evaluation of long-term biochemical responses to combination therapy of interferon plus ribavirin in those infected with hepatitis C virus genotype 1b and high baseline viral load. Year Published: 2007
Department of Hepatology, Toranomon Hospital, Tokyo, Japan.
4. Efficacy and anticarcinogenic activity of interferon for hepatitis C virus-related compensated cirrhosis in patients with genotype 1b low viral load or genotype 2. Year Published: 2007
Department of Hepatology, Toranomon Hospital, Tokyo, Japan.
5. Glycyrrhizin injection therapy prevents hepatocellular carcinogenesis in patients with interferon-resistant active chronic hepatitis C. Year Published: 2007
Department of Hepatology, Toranomon Hospital, Tokyo, Japan.
6. Amino acid substitutions in the hepatitis C virus core region are the important predictor of hepatocarcinogenesis. Year Published: 2007
Department of Hepatology, Toranomon Hospital, Tokyo, Japan. akuta-gi@umin.ac.jp
7. Side effects of combination therapy of peginterferon and ribavirin for chronic hepatitis-C. Year Published: 2007
Department of Hepatology, Toranomon Hospital.
8. Prolonged hepatitis after acute infection with genotype h hepatitis B virus. Year Published: 2007
Department of Hepatology, Toranomon Hospital.
9. Clinicopathological improvement of non-alcoholic steatohepatitis associated with weight loss during a 14-year follow-up period. Year Published: 2007
Department of Hepatology, Toranomon Hospital, Tokyo, Japan, and Okinaka Memorial Institute for Medical Research, Tokyo, Japan.
10. Side effects of combination therapy of peginterferon and ribavirin for chronic hepatitis-C. Year Published: 2007
Department of Hepatology, Toranomon Hospital, Tokyo. es9y-ars@asahi-net.or.jp
11. Prolonged hepatitis after acute infection with genotype H hepatitis B virus. Year Published: 2007
Department of Hepatology, Toranomon Hospital, Tokyo.
12. Viral elimination reduces incidence of malignant lymphoma in patients with hepatitis C. Year Published: 2007
Department of Hepatology, Toranomon Hospital, Tokyo, Japan. k-yusuke@toranomon.gr.jp
13. Amino acid substitutions in the hepatitis C virus core region are the important predictor of hepatocarcinogenesis. Year Published: 2007
Department of Hepatology, Toranomon Hospital, Tokyo, Japan. akuta-gi@umin.ac.jp
14. Side effects of combination therapy of peginterferon and ribavirin for chronic hepatitis-C. Year Published: 2007
Department of Hepatology, Toranomon Hospital, Tokyo. es9y-ars@asahi-net.or.jp
15. Prolonged hepatitis after acute infection with genotype H hepatitis B virus. Year Published: 2007
Department of Hepatology, Toranomon Hospital, Tokyo.
16. Viral elimination reduces incidence of malignant lymphoma in patients with hepatitis C. Year Published: 2007
Department of Hepatology, Toranomon Hospital, Tokyo, Japan. k-yusuke@toranomon.gr.jp
17. Changes in viral loads of lamivudine-resistant mutants during entecavir therapy. Year Published: 2008
Department of Hepatology, Toranomon Hospital, Tokyo, Japan.
18. Clinicopathological improvement of non-alcoholic steatohepatitis associated with weight loss during a 14-year follow-up period. Year Published: 2007
Department of Hepatology, Toranomon Hospital, Tokyo, Japan.
19. Viral elimination reduces incidence of malignant lymphoma in patients with hepatitis C. Year Published: 2007
Department of Hepatology, Toranomon Hospital, Tokyo, Japan. k-yusuke@toranomon.gr.jp
20. Changes in viral loads of lamivudine-resistant mutants during entecavir therapy. Year Published: 2008
Department of Hepatology, Toranomon Hospital, Tokyo, Japan.
21. [Organic cause of emotional depression] Year Published: 2008
22. Clinicopathological improvement of non-alcoholic steatohepatitis associated with weight loss during a 14-year follow-up period. Year Published: 2007
Department of Hepatology, Toranomon Hospital, Tokyo, Japan.
23. Assessment of Palliative Care Team Activities-Survey of Medications Prescribed Immediately before and at the Beginning of Opioid Usage-. Year Published: 2008
Laboratory of Clinical Pharmaceutics, Faculty of Pharmacy, Osaka Ohtani University.
24. [Organic cause of emotional depression] Year Published: 2008
25. New ablation procedure for a radiofrequency liver tissue coagulation system using an expandable needle. Year Published: 2008
Department of Hepatology, Toranomon Hospital, Tokyo, Japan.
26. Assessment of palliative care team activities--survey of medications prescribed immediately before and at the beginning of opioid usage. Year Published: 2008
Laboratory of Clinical Pharmaceutics, Faculty of Pharmacy, Osaka Ohtani University, Tondabayashi City, Japan. myoutom@osaka-ohtani.ac.jp
27. [Anti-viral therapy of type B chronic hepatitis. 1. Selection of evidence-based therapeutic policy] Year Published: 2008
28. New ablation procedure for a radiofrequency liver tissue coagulation system using an expandable needle. Year Published: 2008
Department of Hepatology, Toranomon Hospital, Tokyo, Japan. ZXC00701@nifty.ne.jp
29. Efficacy in patients with dose reduction in combination therapy of peginterferon and ribavirin for chronic hepatitis C. Year Published: 2008
Department of Hepatology, Toranomon Hospital, Tokyo, Japan. es9y-ars@asahi-net.or.jp